McKinsey January 10, 2025
Shubham Singhal, Neha Patel, with Ankit Jain

Industry economics are shifting toward non-acute care delivery, healthcare software, data, analytics, and specialty pharmacy segments.

Since 2019, the United States healthcare industry has experienced substantial financial pressure, with industry EBITDA as a proportion of the National Health Expenditure declining by an estimated 150 basis points (Exhibit 1). The decline has hit payers and providers particularly hard—payers’ estimated margins in 2024 could be at their lowest in a decade. Inflationary pressures have not yet been fully absorbed within the healthcare system, and providers continue to face labor shortages. Adding to these challenges is constrained reimbursement growth, where providers are dealing with a shifting payer mix, as the share of Medicaid and Medicare enrollment grew from 43 percent in 2019 to...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Analytics, Health IT, Healthcare System, Insurance, Pharma, Pharma / Biotech, Provider, Technology
Trump administration pulls billions in COVID funds, and health leaders warn of lasting damage
HIMSS Changemaker: Lean into your strengths and get involved
Where Americans spend the most on health care
Ranked: Which AI Chatbots Collect the Most Data About You?
Nutrition Funding Cuts Could Claim 369K Young Lives This Year

Share This Article